Clinical development of WEE1 inhibitors in gynecological cancers: A systematic review

This publication has 44 references indexed in Scilit:

• Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors
  Journal of Clinical Oncology, 2015
• Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions
  Gynecologic Oncology, 2014
• Integrated genomic characterization of endometrial carcinoma
  Nature, 2013
• Targeting the S and G2 checkpoint to treat cancer
  Drug Discovery Today, 2012
• WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe
  Clinical Cancer Research, 2011
• Integrated genomic analyses of ovarian carcinoma
  Nature, 2011
• Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets
  PLOS ONE, 2009
• G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
  British Journal of Cancer, 2008
• CDC25 phosphatases in cancer cells: key players? Good targets?
  Nature Reviews Cancer, 2007
• The role of TP53 in Cervical carcinogenesis
  Human Mutation, 2003